Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Genetic stability in two commercialized transgenic lines (MON810)

Nature Biotechnology volume 28, page 779 (2010)Cite this article

Subjects

Access through your institution
Buy or subscribe

To the Editor:

A letter of correspondence by Dany Morisset and his colleagues1 in the August 2009 issue cites two recent publications2,3 in which “two commercial seed varieties of the MON810 maize genetically modified event (ARISTIS BT and CGS4540) present genetic variation thus hampering the detection by several methods for MON810 (Monsanto, St. Louis).” As representatives of Monsanto Europe (Brussels), Syngenta Crop Protection (Basel) and Limagrain Services Holding (Chappes, France), we would like to correct the scientific record concerning the claimed “variation” of the transgenic insertion in these transgenic hybrids.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Morisset, D. et al. Nat. Biotechnol. 27, 700–701 (2009).

    Article  CAS  Google Scholar 

  2. Aguilera, M. et al. Food Anal. Methods 1, 252–258 (2008).

    Article  Google Scholar 

  3. Aguilera, M. et al. Food Anal. Methods 2, 73–79 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Limagrain Services Holding, Quality Assurance, Chappes, France

    Sofia Ben Tahar

  2. Syngenta Crop Protection AG, Regulatory Affairs, Basel, Switzerland

    Isabelle Salva

  3. Monsanto Europe SA, Scientific Affairs, Brussels, Belgium

    Ivo O Brants

Authors
  1. Sofia Ben Tahar
    View author publications

    Search author on:PubMed Google Scholar

  2. Isabelle Salva
    View author publications

    Search author on:PubMed Google Scholar

  3. Ivo O Brants
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Ivo O Brants.

Ethics declarations

Competing interests

Monsanto, Syngenta and Limagrain are commercializing the transgenic events/hybrids referred to in the correspondence.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tahar, S., Salva, I. & Brants, I. Genetic stability in two commercialized transgenic lines (MON810). Nat Biotechnol 28, 779 (2010). https://doi.org/10.1038/nbt0810-779b

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0810-779b

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing